Looks like they are set up for a pretty strong FY25. Good to see $300K cash flow positive for the qtr. If they can get anywhere near the bottom end of their guidance range of $4M / $5.5M there should be a huge re rate in share price. above that a bonus in my view.
$2M banked from recent raising and another $1M banked from sale of Myaccess clinics should hold off any need for another near term raise.
Looks like pivotal moment for the company if can achieve their forecasts. Given the companies underperformance for many years any scepticism is also understandable until they prove themselves.
$8.3M revenue for the qtr and receipts for $7.5M. looks like Company still hasn't been paid for ~$800K which I assume should roll into this qtr.
mkt cap still only $17M. Any news on signing distribution deals would be another major catalyst.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)